Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carolyn A Goard

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Core Evidence|March 22, 2013
An evidence-based review of obatoclax mesylate in the treatment of hematological malignanciesCarolyn A Goard, Aaron D Schimmer
BMC Cancer|March 20, 2010
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevanceAnna Martirosyan, James W Clendening, Carolyn A Goard, et al.
Molecular Oncology|April 23, 2009
A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locusCarolyn A Goard, Irvin L Bromberg, Marc B Elliott, et al.
Plos One|May 30, 2014
A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activityYulia Jitkova, Marcela Gronda, Rose Hurren, et al.
Cell Biochemistry and Function|August 24, 2006
The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoproteinYanjun Shu, Nina D Rintala-Maki, Vanessa E Wall, et al.
International Journal of Cancer|February 26, 2011
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agentsCarolyn A Goard, Richard G Mather, Balpreet Vinepal, et al.
Journal of Cellular Biochemistry|November 30, 2006
Expression of RBM5-related factors in primary breast tissueNina D Rintala-Maki, Carolyn A Goard, Colleen E Langdon, et al.
Breast Cancer Research and Treatment|December 17, 2013
Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cellsCarolyn A Goard, Michelle Chan-Seng-Yue, Peter J Mullen, et al.
Oncotarget|September 11, 2015
Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell deathAleksandra A Pandyra, Peter J Mullen, Carolyn A Goard, et al.
Plos One|April 3, 2014
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cellsG Wei Xu, Julia I Toth, Sara R da Silva, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Core Evidence|March 22, 2013
An evidence-based review of obatoclax mesylate in the treatment of hematological malignanciesCarolyn A Goard, Aaron D Schimmer
BMC Cancer|March 20, 2010
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevanceAnna Martirosyan, James W Clendening, Carolyn A Goard, et al.
Molecular Oncology|April 23, 2009
A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locusCarolyn A Goard, Irvin L Bromberg, Marc B Elliott, et al.
Plos One|May 30, 2014
A novel formulation of tigecycline has enhanced stability and sustained antibacterial and antileukemic activityYulia Jitkova, Marcela Gronda, Rose Hurren, et al.
Cell Biochemistry and Function|August 24, 2006
The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoproteinYanjun Shu, Nina D Rintala-Maki, Vanessa E Wall, et al.
International Journal of Cancer|February 26, 2011
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agentsCarolyn A Goard, Richard G Mather, Balpreet Vinepal, et al.
Journal of Cellular Biochemistry|November 30, 2006
Expression of RBM5-related factors in primary breast tissueNina D Rintala-Maki, Carolyn A Goard, Colleen E Langdon, et al.
Breast Cancer Research and Treatment|December 17, 2013
Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cellsCarolyn A Goard, Michelle Chan-Seng-Yue, Peter J Mullen, et al.
Oncotarget|September 11, 2015
Genome-wide RNAi analysis reveals that simultaneous inhibition of specific mevalonate pathway genes potentiates tumor cell deathAleksandra A Pandyra, Peter J Mullen, Carolyn A Goard, et al.
Plos One|April 3, 2014
Mutations in UBA3 confer resistance to the NEDD8-activating enzyme inhibitor MLN4924 in human leukemic cellsG Wei Xu, Julia I Toth, Sara R da Silva, et al.
Pageof 2